Susquehanna International Group, LLP Clearside Biomedical, Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$0.93 - $1.35 $13,392 - $19,440	14,400 New	14,400 $18,000
Q3 2023 Nov 14, 2023	SELL	$0.82 - $1.27 $4,428 - $6,858	-5,400 Reduced 7.75%	64,300 $55,000
Q2 2023 Aug 11, 2023	BUY	$0.97 - $1.48 $8,245 - $12,580	8,500 Added 13.89%	69,700 $78,000
Q1 2023 May 16, 2023	BUY	$0.93 - $1.66 $37,107 - $66,234	39,900 Added 187.32%	61,200 $63,000
Q4 2022 Feb 14, 2023	SELL	$1.0 - $1.5 $123,700 - $185,550	-123,700 Reduced 85.31%	21,300 $23,000
Q3 2022 Nov 14, 2022	SELL	$1.08 - $1.83 $13,392 - $22,692	-12,400 Reduced 7.88%	145,000 $164,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $56M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.